Eva M. Sevick, Ph.D. is Professor and the Nancy and Rich Kinder Distinguished Chair of Cardiovascular Disease Research at the University of Texas Health Science Center’s Institute of Molecular Medicine (IMM) where she currently directs the Center for Molecular Imaging. At the IMM she leads the National Cancer Institute Center for Translational Research which focuses upon the development and validation of new imaging instrumentation, algorithms, and imaging agents and their clinical translation. She has pioneered the development of near-infrared fluorescence optical imaging and tomography for molecular imaging and currently has two clinical trials underway at the University of Texas Health Science Center and Memorial Hermann Hospital that employ the technology for novel diagnostic imaging of lymphatic function. Her team is active in preclinical, small animal imaging with nuclear and optical techniques and is pioneering diagnostic imaging for nodal staging in cancer.

Dr. Sevick received her Ph.D. in Chemical Engineering at Carnegie Mellon University with Rakesh Jain, her post-doctoral training in Biochemistry and Biophysics at the University of Pennsylvania with Britton Chance, and has served on the faculties at Vanderbilt, Purdue, Texas A&M as well as Baylor College of Medicine. She is past recipient of the National Science Foundation Young Investigator Award, the National Institutes of Health Research Career Award, and the American Cancer Society Research Scholar Award and has served as an appointed member of the Biomedical Imaging Study section, associate editor of the IEEE Transactions of Medical Imaging, and officer of the Society of Molecular Imaging.

Health, Healthcare, Women's Health, Healthcare Futurism, Healthcare Providers, Professors, Education Professionals, Molecular Biology, Cancer, Lymphoma Chemical Engineering, Chemistry,